Document Report Card

Basic Information

ID: ALA1156956

Journal: Bioorg Med Chem Lett

Title: Triazines incorporating (R)-3-methylmorpholine are potent inhibitors of the mammalian target of rapamycin (mTOR) with selectivity over PI3Kalpha.

Authors: Richard DJ, Verheijen JC, Yu K, Zask A.

Abstract: Potent inhibitors of the mammalian target of rapamycin (mTOR) which contain the triazine scaffold and the (R)-3-methyl morpholine moiety have been identified. Such compounds also demonstrated good selectivity over the related lipid kinase PI3Kalpha. Incorporation of additional functionality at the 4-position of the arylureidophenyl ring resulted in compounds with enhanced cellular activity.

CiteXplore: 20223664

DOI: 10.1016/j.bmcl.2010.02.029